Cardinal Health, Inc (NYSE: CAH) has seen a rise in its stock price by 2.62 in relation to its previous close of 120.86. However, the company has experienced a 3.68% gain in its stock price over the last five trading sessions. seekingalpha.com reported 2025-01-14 that Cardinal Health, Inc. (NYSE:CAH ) J.P. Morgan Healthcare Conference January 14, 2025 12:00 PM ET Company Participants Aaron Alt – CFO Jason Hollar – CEO Conference Call Participants Lisa Gill – JPMorgan Lisa Gill Good morning.
Is It Worth Investing in Cardinal Health, Inc (NYSE: CAH) Right Now?
Cardinal Health, Inc (NYSE: CAH) has a price-to-earnings ratio that is above its average at 24.10x. The stock has a 36-month beta value of 0.64. Opinions on the stock are mixed, with 8 analysts rating it as a “buy,” 2 as “overweight,” 9 as “hold,” and 0 as “sell.”
The public float for CAH is 241.34M, and at present, short sellers hold a 1.75% of that float. On January 15, 2025, the average trading volume of CAH was 2.14M shares.
CAH’s Market Performance
The stock of Cardinal Health, Inc (CAH) has seen a 3.68% increase in the past week, with a 5.63% rise in the past month, and a 10.24% gain in the past quarter. The volatility ratio for the week is 2.15%, and the volatility levels for the past 30 days are at 1.76% for CAH. The simple moving average for the last 20 days is 4.20% for CAH stock, with a simple moving average of 14.51% for the last 200 days.
Analysts’ Opinion of CAH
Many brokerage firms have already submitted their reports for CAH stocks, with TD Cowen repeating the rating for CAH by listing it as a “Buy.” The predicted price for CAH in the upcoming period, according to TD Cowen is $144 based on the research report published on January 08, 2025 of the current year 2025.
Evercore ISI, on the other hand, stated in their research note that they expect to see CAH reach a price target of $140. The rating they have provided for CAH stocks is “Outperform” according to the report published on January 07th, 2025.
BofA Securities gave a rating of “Buy” to CAH, setting the target price at $145 in the report published on January 06th of the current year.
CAH Trading at 3.67% from the 50-Day Moving Average
After a stumble in the market that brought CAH to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -1.74% of loss for the given period.
Volatility was left at 1.76%, however, over the last 30 days, the volatility rate increased by 2.15%, as shares surge +5.59% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +14.96% upper at present.
During the last 5 trading sessions, CAH rose by +3.68%, which changed the moving average for the period of 200-days by +10.21% in comparison to the 20-day moving average, which settled at $119.04. In addition, Cardinal Health, Inc saw 4.87% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CAH starting from Scherer Mary C., who sale 3,504 shares at the price of $123.55 back on Nov 14 ’24. After this action, Scherer Mary C. now owns 8,752 shares of Cardinal Health, Inc, valued at $432,919 using the latest closing price.
Mayer Jessica L, the Chief Legal/Compliance Officer of Cardinal Health, Inc, sale 16,573 shares at $109.39 during a trade that took place back on Aug 21 ’24, which means that Mayer Jessica L is holding 75,971 shares at $1,812,920 based on the most recent closing price.
Stock Fundamentals for CAH
Current profitability levels for the company are sitting at:
- 0.01 for the present operating margin
- 0.03 for the gross margin
The net margin for Cardinal Health, Inc stands at 0.01. The total capital return value is set at 0.26.
Based on Cardinal Health, Inc (CAH), the company’s capital structure generated 2.74 points at debt to capital in total, while cash flow to debt ratio is standing at 0.3. The debt to equity ratio resting at -1.58. The interest coverage ratio of the stock is 24.53.
Currently, EBITDA for the company is 1.98 billion with net debt to EBITDA at 0.89. When we switch over and look at the enterprise to sales, we see a ratio of 0.14. The receivables turnover for the company is 19.06for trailing twelve months and the total asset turnover is 5.21. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.95.
Conclusion
To sum up, Cardinal Health, Inc (CAH) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
